Skip to main content
Erschienen in: Journal of Assisted Reproduction and Genetics 6/2012

01.06.2012 | Genetics

Genetic screening for chromosomal abnormalities and Y chromosome microdeletions in Chinese infertile men

verfasst von: Li Fu, Da-Ke Xiong, Xian-Ping Ding, Chuang Li, Li-Yuan Zhang, Min Ding, Shuang-Shuang Nie, Qiang Quan

Erschienen in: Journal of Assisted Reproduction and Genetics | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

Purposes

To investigate the frequency and type of both chromosomal abnormalities and Y chromosome microdeletions and analyze their association with defective spermatogenesis in Chinese infertile men.

Methods

This is a single center study. Karyotyping using G-banding and screening for Y chromosome microdeletion by multiplex polymerase chain reactio(PCR)were performed in 200 controls and 1,333 infertile men, including 945 patients with non-obstructive azoospermia and 388 patients with severe oligozoospermia.

Results

Out of 1,333 infertile patients, 154(11.55%) presented chromosomal abnormalities. Of these, 139 of 945 (14.71%) were from the azoospermic and 15 of 388 (3.87%) from the severe oligozoospermic patient groups. The incidence of sex chromosomal abnormalities in men with azoospermia was 11.53% compared with 1.03% in men with severe oligozoospermia (P < 0.01). Also 144 of 1,333(10.80%) patients presented Y chromosome microdeletions. The incidence of azoospermia factor(AZF) microdeletion was 11.75% and 8.51% in patients with azoospermia and severe oligozoospermia respectively. Deletion of AZFc was the most common and deletions in AZFa or AZFab or AZFabc were found in azoospermic men. In addition, 34 patients had chromosomal abnormalities among the 144 patients with Y chromosome microdeletions. No chromosomal abnormality and microdeletion in AZF region were detected in controls.

Conclusions

There was a high incidence (19.80%) of chromosomal abnormalities and Y chromosomal microdeletions in Chinese infertile males with azoospermia or severe oligozoospermia. These findings strongly suggest that genetic screening should be advised to infertile men before starting assisted reproductive treatments.
Literatur
1.
Zurück zum Zitat Akin H, Onay H, Turker E, Ozkinay F. Primary male infertility in Izmir/Turkey: a cytogenetic and molecular study of 187 infertile Turkish patients. J Assist Reprod Genet. 2011;1–5. Akin H, Onay H, Turker E, Ozkinay F. Primary male infertility in Izmir/Turkey: a cytogenetic and molecular study of 187 infertile Turkish patients. J Assist Reprod Genet. 2011;1–5.
2.
Zurück zum Zitat Ali M, Hayat M. Screening of ‘Y’ chromosome microdeletions in Iranian infertile males. J Hum Reprod Sci. 2008;1:2–9.CrossRef Ali M, Hayat M. Screening of ‘Y’ chromosome microdeletions in Iranian infertile males. J Hum Reprod Sci. 2008;1:2–9.CrossRef
3.
Zurück zum Zitat Brennan J, Capel B. One tissue, two fates: molecular genetic events that underlie testis versus ovary development. Nat Rev Genet. 2004;5(7):509–21.PubMedCrossRef Brennan J, Capel B. One tissue, two fates: molecular genetic events that underlie testis versus ovary development. Nat Rev Genet. 2004;5(7):509–21.PubMedCrossRef
4.
Zurück zum Zitat Carrell D, De Jonge C, Lamb D. The genetics of male infertility: a field of study whose time is now. Syst Biol Reprod Med. 2006;52(4):269–74.CrossRef Carrell D, De Jonge C, Lamb D. The genetics of male infertility: a field of study whose time is now. Syst Biol Reprod Med. 2006;52(4):269–74.CrossRef
5.
Zurück zum Zitat Carrell DT. Contributions of spermatozoa to embryogenesis: assays to evaluate their genetic and epigenetic fitness. Reprod Biomed Online. 2008;16(4):474–84.PubMedCrossRef Carrell DT. Contributions of spermatozoa to embryogenesis: assays to evaluate their genetic and epigenetic fitness. Reprod Biomed Online. 2008;16(4):474–84.PubMedCrossRef
8.
Zurück zum Zitat De Kretser D, Baker H. Infertility in men: recent advances and continuing controversies. J Clin Endocrinol Metab. 1999;84(10):3443.PubMedCrossRef De Kretser D, Baker H. Infertility in men: recent advances and continuing controversies. J Clin Endocrinol Metab. 1999;84(10):3443.PubMedCrossRef
9.
Zurück zum Zitat El Awady MK, El Shater SF, Ragaa E, Atef K, Shaheen IM, Megiud NA. Molecular study on Y chromosome microdeletions in Egyptian males with idiopathic infertility. Asian J Androl. 2004;6(1):53–8.PubMed El Awady MK, El Shater SF, Ragaa E, Atef K, Shaheen IM, Megiud NA. Molecular study on Y chromosome microdeletions in Egyptian males with idiopathic infertility. Asian J Androl. 2004;6(1):53–8.PubMed
10.
Zurück zum Zitat Elghezal H, Hidar S, Braham R, Denguezli W, Ajina M, Saâd A. Chromosome abnormalities in one thousand infertile males with nonobstructive sperm disorders. Fertil Steril. 2006;86(6):1792–5.PubMedCrossRef Elghezal H, Hidar S, Braham R, Denguezli W, Ajina M, Saâd A. Chromosome abnormalities in one thousand infertile males with nonobstructive sperm disorders. Fertil Steril. 2006;86(6):1792–5.PubMedCrossRef
11.
Zurück zum Zitat Ferlin A, Arredi B, Speltra E, Cazzadore C, Selice R, Garolla A, Lenzi A, Foresta C. Molecular and clinical characterization of Y chromosome microdeletions in infertile men: a 10-year experience in Italy. J Clin Endocrinol Metab. 2007;92(3):762.PubMedCrossRef Ferlin A, Arredi B, Speltra E, Cazzadore C, Selice R, Garolla A, Lenzi A, Foresta C. Molecular and clinical characterization of Y chromosome microdeletions in infertile men: a 10-year experience in Italy. J Clin Endocrinol Metab. 2007;92(3):762.PubMedCrossRef
12.
Zurück zum Zitat Ferlin A, Raicu F, Gatta V, Zuccarello D, Palka G, Foresta C. Male infertility: role of genetic background. Reprod BioMed Online. 2007;14(6):734–45.PubMedCrossRef Ferlin A, Raicu F, Gatta V, Zuccarello D, Palka G, Foresta C. Male infertility: role of genetic background. Reprod BioMed Online. 2007;14(6):734–45.PubMedCrossRef
13.
Zurück zum Zitat Foresta C, Garolla A, Bartoloni L, Bettella A, Ferlin A. Genetic abnormalities among severely oligospermic men who are candidates for intracytoplasmic sperm injection. J Clin Endocrinol Metab. 2005;90(1):152.PubMedCrossRef Foresta C, Garolla A, Bartoloni L, Bettella A, Ferlin A. Genetic abnormalities among severely oligospermic men who are candidates for intracytoplasmic sperm injection. J Clin Endocrinol Metab. 2005;90(1):152.PubMedCrossRef
14.
Zurück zum Zitat Foresta C, Moro E, Ferlin A. Y chromosome microdeletions and alterations of spermatogenesis. Endocr Rev. 2001;22(2):226–39.PubMedCrossRef Foresta C, Moro E, Ferlin A. Y chromosome microdeletions and alterations of spermatogenesis. Endocr Rev. 2001;22(2):226–39.PubMedCrossRef
15.
Zurück zum Zitat Hofherr SE, Wiktor AE, Kipp BR, Dawson DB, Van Dyke DL. Clinical diagnostic testing for the cytogenetic and molecular causes of male infertility: the Mayo Clinic experience. J Assist Reprod Genet. 2011;1–8. Hofherr SE, Wiktor AE, Kipp BR, Dawson DB, Van Dyke DL. Clinical diagnostic testing for the cytogenetic and molecular causes of male infertility: the Mayo Clinic experience. J Assist Reprod Genet. 2011;1–8.
16.
Zurück zum Zitat Jaruzelska J, Korcz A, Wojda A, Jedrzejczak P, Bierla J, Surmacz T, Pawelczyk L, Page DC, Kotecki M. Mosaicism for 45, X cell line may accentuate the severity of spermatogenic defects in men with AZFc deletion. J Med Genet. 2001;38(11):798.PubMedCrossRef Jaruzelska J, Korcz A, Wojda A, Jedrzejczak P, Bierla J, Surmacz T, Pawelczyk L, Page DC, Kotecki M. Mosaicism for 45, X cell line may accentuate the severity of spermatogenic defects in men with AZFc deletion. J Med Genet. 2001;38(11):798.PubMedCrossRef
17.
Zurück zum Zitat Lian J, Zhang X, Tian H, Liang N, Wang Y, Liang C, Li X, Sun F. Altered microRNA expression in patients with non-obstructive azoospermia. Reprod Biol Endocrinol. 2009;7:13.PubMedCrossRef Lian J, Zhang X, Tian H, Liang N, Wang Y, Liang C, Li X, Sun F. Altered microRNA expression in patients with non-obstructive azoospermia. Reprod Biol Endocrinol. 2009;7:13.PubMedCrossRef
18.
Zurück zum Zitat Mahanta R, Gogoi A, Roy S, Bhattacharyya I, Sharma P. Prevalence of Azoospermia Factor (AZF) deletions in idiopathic infertile males in North-East India. Int J Hum Genet. 2011;11(2):99–104. Mahanta R, Gogoi A, Roy S, Bhattacharyya I, Sharma P. Prevalence of Azoospermia Factor (AZF) deletions in idiopathic infertile males in North-East India. Int J Hum Genet. 2011;11(2):99–104.
19.
Zurück zum Zitat Margarit E, Soler A, Carrio A, Oliva R, Costa D, Vendrell T, Rosell J, Ballesta F. Molecular, cytogenetic, and clinical characterisation of six XX males including one prenatal diagnosis. J Med Genet. 1998;35(9):727–30.PubMedCrossRef Margarit E, Soler A, Carrio A, Oliva R, Costa D, Vendrell T, Rosell J, Ballesta F. Molecular, cytogenetic, and clinical characterisation of six XX males including one prenatal diagnosis. J Med Genet. 1998;35(9):727–30.PubMedCrossRef
20.
Zurück zum Zitat Martinez-Garza SG, Gallegos-Rivas MC, Vargas-Maciel M, Rubio-Rubio JM, de los Monteros-Rodriguez ME, Gonzalez-Ortega C, Cancino-Villarreal P, de Lara LGV, Gutierrez-Gutierrez AM. Genetic screening in infertile Mexican men: chromosomal abnormalities, Y chromosome deletions, and androgen receptor CAG repeat length. J Androl. 2008;29(6):654.PubMedCrossRef Martinez-Garza SG, Gallegos-Rivas MC, Vargas-Maciel M, Rubio-Rubio JM, de los Monteros-Rodriguez ME, Gonzalez-Ortega C, Cancino-Villarreal P, de Lara LGV, Gutierrez-Gutierrez AM. Genetic screening in infertile Mexican men: chromosomal abnormalities, Y chromosome deletions, and androgen receptor CAG repeat length. J Androl. 2008;29(6):654.PubMedCrossRef
21.
Zurück zum Zitat Organization WH. WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction. 4th ed. Cambridge: Cambridge University Press; 1999. Organization WH. WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction. 4th ed. Cambridge: Cambridge University Press; 1999.
22.
Zurück zum Zitat Paquis-Flucklinger V, Santucci-Darmanin S, Paul R, Saunieres A, Turc-Carel C, Desnuelle C. Cloning and expression analysis of a meiosis-specific MutS homolog: the HumanMSH4Gene. Genomics. 1997;44(2):188–94.PubMedCrossRef Paquis-Flucklinger V, Santucci-Darmanin S, Paul R, Saunieres A, Turc-Carel C, Desnuelle C. Cloning and expression analysis of a meiosis-specific MutS homolog: the HumanMSH4Gene. Genomics. 1997;44(2):188–94.PubMedCrossRef
23.
Zurück zum Zitat Patsalis PC, Sismani C, Quintana-Murci L, Taleb-Bekkouche F, Krausz C, McElreavey K. Effects of transmission of Y chromosome AZFc deletions. Lancet. 2002;360(9341):1222–4.PubMedCrossRef Patsalis PC, Sismani C, Quintana-Murci L, Taleb-Bekkouche F, Krausz C, McElreavey K. Effects of transmission of Y chromosome AZFc deletions. Lancet. 2002;360(9341):1222–4.PubMedCrossRef
24.
Zurück zum Zitat Repping S, Skaletsky H, Lange J, Silber S, Van der Veen F, Oates RD, Page DC, Rozen S. Recombination between palindromes P5 and P1 on the human Y chromosome causes massive deletions and spermatogenic failure. Am J Hum Genet. 2002;71(4):906–22.PubMedCrossRef Repping S, Skaletsky H, Lange J, Silber S, Van der Veen F, Oates RD, Page DC, Rozen S. Recombination between palindromes P5 and P1 on the human Y chromosome causes massive deletions and spermatogenic failure. Am J Hum Genet. 2002;71(4):906–22.PubMedCrossRef
25.
Zurück zum Zitat Shaffer LG, Tommerup N. ISCN 2005: an international system for human cytogenetic nomenclature (2005): recommendations of the International Standing Committee on Human Cytogenetic Nomenclature. S Karger Pub. 2005. Shaffer LG, Tommerup N. ISCN 2005: an international system for human cytogenetic nomenclature (2005): recommendations of the International Standing Committee on Human Cytogenetic Nomenclature. S Karger Pub. 2005.
26.
Zurück zum Zitat Simoni M, Bakker E, Krausz C. EAA/EMQN best practice guidelines for molecular diagnosis of y-chromosomal microdeletions. State of the art 2004. Int J Androl. 2004;27(4):240–9.PubMedCrossRef Simoni M, Bakker E, Krausz C. EAA/EMQN best practice guidelines for molecular diagnosis of y-chromosomal microdeletions. State of the art 2004. Int J Androl. 2004;27(4):240–9.PubMedCrossRef
27.
Zurück zum Zitat Simoni M, Tuttelmann F, Gromoll J, Nieschlag E. Clinical consequences of microdeletions of the Y chromosome: the extended Münster experience. Reprod BioMed Online. 2008;16(2):289–303.PubMedCrossRef Simoni M, Tuttelmann F, Gromoll J, Nieschlag E. Clinical consequences of microdeletions of the Y chromosome: the extended Münster experience. Reprod BioMed Online. 2008;16(2):289–303.PubMedCrossRef
28.
Zurück zum Zitat Sinclair A, Berta P, Palmer M, Hawkins J, Griffiths B. A gene from the human sex-determining region encodes a protein with. Nature. 1990;346(6281):240–4.PubMedCrossRef Sinclair A, Berta P, Palmer M, Hawkins J, Griffiths B. A gene from the human sex-determining region encodes a protein with. Nature. 1990;346(6281):240–4.PubMedCrossRef
29.
Zurück zum Zitat Tiepolo L, Zuffardi O. Localization of factors controlling spermatogenesis in the nonfluorescent portion of the human Y chromosome long arm. Hum Genet. 1976;34(2):119–24.PubMedCrossRef Tiepolo L, Zuffardi O. Localization of factors controlling spermatogenesis in the nonfluorescent portion of the human Y chromosome long arm. Hum Genet. 1976;34(2):119–24.PubMedCrossRef
30.
Zurück zum Zitat Van Assche E, Bonduelle M, Tournaye H, Joris H, Verheyen G, Devroey P, Van Steirteghem A, Liebaers I. Cytogenetics of infertile men. Hum Reprod. 1996;11 suppl 4:1.PubMedCrossRef Van Assche E, Bonduelle M, Tournaye H, Joris H, Verheyen G, Devroey P, Van Steirteghem A, Liebaers I. Cytogenetics of infertile men. Hum Reprod. 1996;11 suppl 4:1.PubMedCrossRef
31.
Zurück zum Zitat Velasco G, Pendás AM, Fueyo A, Knäuper V, Murphy G, López-Otín C. Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family members. J Biol Chem. 1999;274(8):4570.PubMedCrossRef Velasco G, Pendás AM, Fueyo A, Knäuper V, Murphy G, López-Otín C. Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family members. J Biol Chem. 1999;274(8):4570.PubMedCrossRef
32.
Zurück zum Zitat Vog P, Edelmann A, Kirsch S, Henegariu O, Hirschmann P, Kiesewetter F, Köhn F, Schill W, Farah S, Ramos C. Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum Mol Genet. 1996;5(7):933.CrossRef Vog P, Edelmann A, Kirsch S, Henegariu O, Hirschmann P, Kiesewetter F, Köhn F, Schill W, Farah S, Ramos C. Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum Mol Genet. 1996;5(7):933.CrossRef
33.
Zurück zum Zitat Wang RX, Fu C, Yang YP, Han RR, Dong Y, Dai RL, Liu RZ. Male infertility in China: laboratory finding for AZF microdeletions and chromosomal abnormalities in infertile men from Northeastern China. J Assist Reprod Genet. 2010;27(7):391–6.PubMedCrossRef Wang RX, Fu C, Yang YP, Han RR, Dong Y, Dai RL, Liu RZ. Male infertility in China: laboratory finding for AZF microdeletions and chromosomal abnormalities in infertile men from Northeastern China. J Assist Reprod Genet. 2010;27(7):391–6.PubMedCrossRef
34.
Zurück zum Zitat Wong WY, Thomas CMG, Merkus JMWM, Zielhuis GA, Steegers-Theunissen RPM. Male factor subfertility: possible causes and the impact of nutritional factors. Fertil Steril. 2000;73(3):435–42.PubMedCrossRef Wong WY, Thomas CMG, Merkus JMWM, Zielhuis GA, Steegers-Theunissen RPM. Male factor subfertility: possible causes and the impact of nutritional factors. Fertil Steril. 2000;73(3):435–42.PubMedCrossRef
35.
Zurück zum Zitat Yang Y, Ma M, Xiao C, Li L, Li S, Zhang S. Massive deletion in AZFb/b+ c and azoospermia with sertoli cell only and/or maturation arrest. Int J Androl. 2008;31(6):573–8.PubMedCrossRef Yang Y, Ma M, Xiao C, Li L, Li S, Zhang S. Massive deletion in AZFb/b+ c and azoospermia with sertoli cell only and/or maturation arrest. Int J Androl. 2008;31(6):573–8.PubMedCrossRef
36.
Zurück zum Zitat Zhang F, Lu C, Li Z, Xie P, Xia Y, Zhu X, Wu B, Cai X, Wang X, Qian J. Partial deletions are associated with an increased risk of complete deletion in AZFc: a new insight into the role of partial AZFc deletions in male infertility. J Med Genet. 2007;44(7):437–44.PubMedCrossRef Zhang F, Lu C, Li Z, Xie P, Xia Y, Zhu X, Wu B, Cai X, Wang X, Qian J. Partial deletions are associated with an increased risk of complete deletion in AZFc: a new insight into the role of partial AZFc deletions in male infertility. J Med Genet. 2007;44(7):437–44.PubMedCrossRef
37.
Zurück zum Zitat Zhu YJ, Liu SY, Wang H, Wei P, Ding XP. The prevalence of azoospermia factor microdeletion on the Y chromosome of Chinese infertile men detected by multi-analyte suspension array technology. Asian J Androl. 2008;10(6):873–81.PubMedCrossRef Zhu YJ, Liu SY, Wang H, Wei P, Ding XP. The prevalence of azoospermia factor microdeletion on the Y chromosome of Chinese infertile men detected by multi-analyte suspension array technology. Asian J Androl. 2008;10(6):873–81.PubMedCrossRef
Metadaten
Titel
Genetic screening for chromosomal abnormalities and Y chromosome microdeletions in Chinese infertile men
verfasst von
Li Fu
Da-Ke Xiong
Xian-Ping Ding
Chuang Li
Li-Yuan Zhang
Min Ding
Shuang-Shuang Nie
Qiang Quan
Publikationsdatum
01.06.2012
Verlag
Springer US
Erschienen in
Journal of Assisted Reproduction and Genetics / Ausgabe 6/2012
Print ISSN: 1058-0468
Elektronische ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-012-9741-y

Weitere Artikel der Ausgabe 6/2012

Journal of Assisted Reproduction and Genetics 6/2012 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.